Related Experiment Videos
Current guidelines have limited applicability to patients with comorbid conditions: a systematic analysis of
Marjolein Lugtenberg1, Jako S Burgers, Carolyn Clancy
1Scientific Centre for Care and Welfare (Tranzo), Tilburg University, Tilburg, The Netherlands. m.lugtenberg@iq.umcn.nl
Insights
Current clinical guidelines offer limited support for managing patients with multiple chronic conditions, particularly for complex comorbidity cases. Future research should focus on these prevalent patient populations.
Area of Science:
- Clinical Practice Guidelines
- Comorbidity Research
- Evidence-Based Medicine
Background:
- Traditional guidelines focus on single diseases, limiting applicability for the nearly half of patients with multiple chronic conditions.
- Assessing guideline support for comorbidity is crucial for improving patient care.
- This study evaluates how well guidelines address comorbidity and the evidence behind their recommendations.
Purpose of the Study:
- To assess the extent to which current evidence-based guidelines address comorbidity.
- To evaluate the supporting evidence for guideline recommendations related to comorbidity.
- To identify limitations in guideline applicability for patients with multiple chronic diseases.
Main Methods:
- Systematic analysis of 20 evidence-based guidelines for four prevalent chronic conditions: COPD, depression, type 2 diabetes, and osteoarthritis.
- Data abstraction focused on guideline content regarding comorbidity (general comments, specific recommendations), comorbidity type (concordant, discordant), and evidence quality (level, translation).
Main Results:
- 17 (85%) guidelines addressed comorbidity, and 14 (70%) offered specific recommendations, but few recommendations were provided (mean 3 per guideline).
- Of 59 comorbidity recommendations, 78% focused on concordant comorbidities, with limited attention to discordant ones (14%).
- Evidence supporting recommendations was often of moderate (25%) or low (37%) strength, and poorly translated into guidelines (73%).
Conclusions:
- Current guidelines have limited applicability for patients with comorbid conditions, especially for discordant comorbidity combinations.
- Guidelines need to be more explicit regarding their recommendations for patients with comorbidity.
- Future clinical trials should prioritize recruiting patients with prevalent combinations of chronic conditions.
Background:
Guidelines traditionally focus on the diagnosis and treatment of single diseases. As almost half of the patients with a chronic disease have more than one disease, the applicability of guidelines may be limited. The aim of this study was to assess the extent that guidelines address comorbidity and to assess the supporting evidence of recommendations related to comorbidity.
Methodology/Principal Findings:
We conducted a systematic analysis of evidence-based guidelines focusing on four highly prevalent chronic conditions with a high impact on quality of life: chronic obstructive pulmonary disease, depressive disorder, diabetes mellitus type 2, and osteoarthritis. Data were abstracted from each guideline on the extent that comorbidity was addressed (general comments, specific recommendations), the type of comorbidity discussed (concordant, discordant), and the supporting evidence of the comorbidity-related recommendations (level of evidence, translation of evidence). Of the 20 guidelines, 17 (85%) addressed the issue of comorbidity and 14 (70%) provided specific recommendations on comorbidity. In general, the guidelines included few recommendations on patients with comorbidity (mean 3 recommendations per guideline, range 0 to 26). Of the 59 comorbidity-related recommendations provided, 46 (78%) addressed concordant comorbidities, 8 (14%) discordant comorbidities, and for 5 (8%) the type of comorbidity was not specified. The strength of the supporting evidence was moderate for 25% (15/59) and low for 37% (22/59) of the recommendations. In addition, for 73% (43/59) of the recommendations the evidence was not adequately translated into the guidelines.
Conclusions/Significance:
Our study showed that the applicability of current evidence-based guidelines to patients with comorbid conditions is limited. Most guidelines do not provide explicit guidance on treatment of patients with comorbidity, particularly for discordant combinations. Guidelines should be more explicit about the applicability of their recommendations to patients with comorbidity. Future clinical trials should also include patients with the most prevalent combinations of chronic conditions.
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Nursing Interventions II: Selecting and Classifying the Nursing Interventions
Drug Dosing: Geriatric Patients
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
Bioequivalence of Drugs: Drugs with Multiple Indications
Guidelines for Writing Outcome
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care evaluation by...